Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    3TREES Sees Asia-Pacific Cooperation as a Win-Win Business Boost

    November 21, 2026

    WFP seeks $12.1 billion to feed 91 million people in 2027

    November 21, 2026

    Guinea declares mpox outbreak over after 42 days without cases

    November 21, 2026
    Oran Star: Algeria’s news. Maghreb perspective.Oran Star: Algeria’s news. Maghreb perspective.
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Oran Star: Algeria’s news. Maghreb perspective.Oran Star: Algeria’s news. Maghreb perspective.
    Home » Russia develops dual-action cancer drug, a game-changer in oncology
    Featured News

    Russia develops dual-action cancer drug, a game-changer in oncology

    March 13, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Scientists at Tomsk Polytechnic University (TPU) have developed and patented Russia’s first theranostic pair original radiopharmaceuticals designed for both the diagnosis and treatment of prostate cancer. According to the TPU press service, the initial phase of pilot clinical trials has been successfully completed, marking a significant advancement in Russian oncology research.

    Russia develops dual-action cancer drug, a game-changer in oncology

    The development is part of a growing field known as theranostics, which combines diagnostic and therapeutic applications into a single approach to cancer treatment. Until now, only two theranostic molecules have been available globally, both developed by foreign companies, targeting neuroendocrine tumors and prostate cancer.

    The Tomsk scientists‘ achievement establishes Russia’s first domestically developed alternative in this field. Roman Zelchan, senior researcher at the Oncoteranostics Research Centre at TPU’s Research School of Chemical and Biomedical Technologies, emphasized the significance of this breakthrough. “We can safely say that Tomsk Polytechnic University has developed the first domestic theranostic pair,” he stated.

    Understanding theranostics: The future of cancer treatment

    Zelchan is also a leading research associate at the Department of Radionuclide Therapy and Diagnostics at the Tomsk Research Institute of Oncology, part of the Tomsk Medical Research Centre. The newly developed radiopharmaceuticals are based on the BQ-PSMA compound, enabling both diagnostic and therapeutic applications. When combined with the diagnostic radioactive isotope technetium-99m, the compound functions as a “signal beacon” that identifies tumor cells.

    The therapeutic version, incorporating lutetium-177, enhances the compound’s ability to target and destroy cancer cells effectively. Prostate cancer remains one of the most commonly diagnosed cancers worldwide, affecting approximately one in eight men during their lifetime. The introduction of this Russian theranostic technology could expand treatment options and improve outcomes for patients.

    The researchers at TPU believe their development represents a major step in advancing personalized cancer treatment within Russia and beyond. With further clinical trials and regulatory approvals, the theranostic pair could potentially become an integral part of modern oncology protocols. This breakthrough aligns with a broader push in Russia to advance domestic pharmaceutical and medical technology sectors, reducing reliance on foreign innovations. – By Eurasian Newswire News Desk.

    Related Posts

    International Ombudsman Forum Establishes Worldwide Independent Defender Union (WIDU)

    November 19, 2026

    Clemta Expands Partner API to Power End-to-End U.S. Business Services

    November 12, 2026

    Finshape launches Agentic DBOS: agentic AI for digital banking, already live in several bank projects

    November 5, 2026

    ARE YOU READY FOR THE BIGGEST IIFA EVER?

    November 5, 2026

    Luma Ventures and KII Formalise Strategic Cooperation to Build the Infrastructure for Kurdistan’s Future Economy

    October 28, 2026

    Integrated Identity Unveils Proprietary Global Media Infrastructure

    October 22, 2026
    Current News

    WFP seeks $12.1 billion to feed 91 million people in 2027

    November 21, 2026

    Guinea declares mpox outbreak over after 42 days without cases

    November 21, 2026

    South Korea’s exports pass $1 trillion for the first time

    November 21, 2026

    Air Arabia Egypt launches Cairo to Al Ain flights now

    November 20, 2026

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales in New Delhi

    November 19, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026
    © 2026 Oran Star | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.